{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:15:28Z","timestamp":1784128528828,"version":"3.55.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2021-4-1","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T09:46:27Z","timestamp":1623145587000},"page":"1-4","source":"Crossref","is-referenced-by-count":11,"title":["Bimekizumab: the new drug in the biologics armamentarium for psoriasis"],"prefix":"10.7573","volume":"10","author":[{"given":"Eg\u00eddio","family":"Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2021,6,8]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2021\/06\/dic.2021-4-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T09:46:28Z","timestamp":1623145588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/bimekizumab:-the-new-drug-in-the-biologics-armamentarium-for-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2021-4-1","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}